Use of Ocular Pharmaceutical Agents for Treatment Purposes
This domain tests certification, the Board formulary, and the line between permitted treatment and prohibited prescribing.
Authority is conditional
New Jersey optometrists do not receive drug authority automatically with the license. Board rules require qualifying education or certification and compliance with the ocular pharmaceutical formulary. Authority covers agents used for diagnosis (topical anesthetics, mydriatics, cycloplegics, dyes) and, for certified licensees, treatment agents such as topical anti-infectives, anti-inflammatories, glaucoma agents, and listed oral agents. Drugs outside the formulary, injectable agents, and surgical procedures are not authorized.
Prescribing discipline
Prescribe only after an examination sufficient to establish a diagnosis; document the drug, dose, duration, and follow-up. Avoid self-prescribing and prescribing for family members except in a documented emergency, and never prescribe outside a bona fide practitioner-patient relationship. Counsel on adverse effects and return precautions. If the condition fails to respond or the diagnosis is uncertain, refer.
Worked example
A certified optometrist diagnoses bacterial conjunctivitis and prescribes a topical fluoroquinolone for seven days with follow-up if not improving. Permitted: a topical anti-infective on the formulary, documented diagnosis, defined follow-up. The same optometrist proposes a subconjunctival steroid injection for severe inflammation. Not permitted: injections are outside optometric authority regardless of the drug; refer or use a permitted topical alternative.
Traps
Assuming "topical" is always allowed and "oral" never is-the formulary controls. Forgetting that certification must be current. Treating without documenting the baseline examination. Missing referral triggers: worsening pain, decreased vision, hypopyon, or no improvement in 48–72 hours. Prescribing analgesia beyond optometric authority instead of referring.